First GSK Ebola vaccine shipment due to arrive in Liberia | Ebola: Laboratory testing protocols for nursing mothers | Over 2.5M reached in emergency anti-malarial effort in Sierra Leone | Ebola vaccine trials may be limited by waning epidemic | Fast track on drug for Ebola has faltered | Avian flu outbreaks in Taiwan trigger human monitoring | Ebola virus variations associated with increasing pathogenicity | A novel mechanism of host immune evasion by Ebola virus | Disneyland measles outbreak reflects anti-vaccination trend | CDC: HAI declined in US hospitals | Trial of 2 Ebola vaccines’ effectiveness is announced | Highly pathogenic avian influenza H5N1 in poultry in Israel | Ebola was only a warm-up: The measles outbreak is for real | Health security and the State of the Union | USDA confirms high-path H5N1 in Washington | Measles is horrible

See what we’re reading this week at Global Biodefense on Ebola vaccine trials, anti-malaria efforts in Sierra Leone, avian influenza outbreaks and more…

First GSK Ebola vaccine shipment due to arrive in Liberia (Reuters)

Ebola: Laboratory testing protocols for nursing mothers (Eurosurveillance)

Over 2.5M reached in emergency anti-malarial effort in Sierra Leone (ReliefWeb)

Ebola vaccine trials may be limited by waning epidemic (Bloomberg)

Fast track on drug for Ebola has faltered (NYTimes)

Avian flu outbreaks in Taiwan trigger human monitoring (CIDRAP)

Ebola virus variations associated with increasing pathogenicity (Genome Biology)

A novel mechanism of host immune evasion by Ebola virus (PLOS Pathogens)

Disneyland measles outbreak reflects anti-vaccination trend (The Guardian)

CDC: HAI declined in US hospitals (Healio)

Trial of 2 Ebola vaccines’ effectiveness is announced (NYTimes)

Highly pathogenic avian influenza H5N1 in poultry in Israel (Gov.UK)